Suzhou Fushilai Pharmaceutical Co. Ltd. - Asset Resilience Ratio

Latest as of June 2025: 45.84%

Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has an Asset Resilience Ratio of 45.84% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 301258 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥977.61 Million

≈ $143.06 Million USD Cash + Short-term Investments

Total Assets

CN¥2.13 Billion

≈ $312.10 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Suzhou Fushilai Pharmaceutical Co. Ltd.'s Asset Resilience Ratio has changed over time. See 301258 net asset value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Suzhou Fushilai Pharmaceutical Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Suzhou Fushilai Pharmaceutical Co. Ltd..

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥977.61 Million	45.84%
Total Liquid Assets	CN¥977.61 Million	45.84%

Asset Resilience Insights

Very High Liquidity: Suzhou Fushilai Pharmaceutical Co. Ltd. maintains exceptional liquid asset reserves at 45.84% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Suzhou Fushilai Pharmaceutical Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare Suzhou Fushilai Pharmaceutical Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Fortress Biotech Inc NASDAQ:FBIO	Biotechnology	11.59%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Apellis Pharmaceuticals Inc NASDAQ:APLS	Biotechnology	0.58%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
BioArctic AB (publ) ST:BIOA-B	Biotechnology	72.35%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%

Annual Asset Resilience Ratio for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Suzhou Fushilai Pharmaceutical Co. Ltd..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	53.80%	CN¥1.12 Billion ≈ $164.35 Million	CN¥2.09 Billion ≈ $305.50 Million	+3.25pp
2023-12-31	50.54%	CN¥1.07 Billion ≈ $156.51 Million	CN¥2.12 Billion ≈ $309.65 Million	-4.78pp
2022-12-31	55.33%	CN¥1.16 Billion ≈ $169.89 Million	CN¥2.10 Billion ≈ $307.06 Million	+53.10pp
2021-12-31	2.23%	CN¥21.61 Million ≈ $3.16 Million	CN¥970.31 Million ≈ $141.99 Million	-13.00pp
2020-12-31	15.22%	CN¥120.00 Million ≈ $17.56 Million	CN¥788.25 Million ≈ $115.35 Million	+12.42pp
2019-12-31	2.81%	CN¥21.10 Million ≈ $3.09 Million	CN¥751.44 Million ≈ $109.96 Million	--

pp = percentage points

About Suzhou Fushilai Pharmaceutical Co. Ltd.

SHE:301258 China Biotechnology

Market Cap

$402.43 Million

CN¥2.75 Billion CNY

Market Cap Rank

#13659 Global

#4313 in China

Share Price

CN¥30.00

Change (1 day)

+0.40%

52-Week Range

CN¥27.75 - CN¥39.02

All Time High

CN¥63.49